How CBD health claims at stores affect what consumers think and do
The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior
This study looks at how the health claims made by stores about CBD products affect what people think and how they buy them, so we can help make sure consumers have the right information and aren’t misled.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10840304 on NIH RePORTER |
What this research studies
This research investigates how health claims about cannabidiol (CBD) products at the point of sale influence consumer perceptions and behaviors. It examines the types of claims made by retailers and how these claims may mislead consumers regarding the safety and efficacy of CBD. By analyzing consumer responses and the potential public health implications, the study aims to inform regulatory actions to ensure that consumers are not misled by unsubstantiated health claims. The research will involve surveys and data collection from various retail environments to assess consumer understanding and decision-making.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 who use or are considering using CBD products for health-related purposes.
Not a fit: Patients who do not use CBD products or are not interested in cannabis-related therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better consumer protection and more accurate information regarding CBD products, helping patients make informed decisions about their health.
How similar studies have performed: While there has been some research on consumer perceptions of CBD, this study aims to address specific regulatory concerns and is considered a novel approach.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Wagoner, Kimberly G. — Wake Forest University Health Sciences
- Study coordinator: Wagoner, Kimberly G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.